Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Physical activity in older subjects is associated with increased coronary vasodilation: the ADVANCE study.

Nguyen PK, Terashima M, Fair JM, Varady A, Taylor-Piliae RE, Iribarren C, Go AS, Haskell WL, Hlatky MA, Fortmann SP, McConnell MV.

JACC Cardiovasc Imaging. 2011 Jun;4(6):622-9. doi: 10.1016/j.jcmg.2011.05.001.

3.

Effects of intravenous atrial natriuretic peptide and nitroglycerin on coronary vasodilation and flow velocity determined using 3 T magnetic resonance imaging in patients with nonischemic heart failure.

Ehara S, Nakamura Y, Matsumoto K, Hasegawa T, Shimada K, Takagi M, Hanatani A, Izumi Y, Terashima M, Yoshiyama M.

Heart Vessels. 2013 Sep;28(5):596-605. doi: 10.1007/s00380-012-0292-z. Epub 2012 Sep 28.

PMID:
23014927
4.

Noninvasive test of nitrate-induced coronary vasomotion by 1.5-T whole-heart 3D magnetic resonance angiography using a T2-prepared SSFP sequence.

Jin H, Zeng MS, Yun H, Ge MY, Ma JY, Yang S.

Int J Cardiovasc Imaging. 2012 Oct;28(7):1707-16. doi: 10.1007/s10554-011-9999-7. Epub 2011 Dec 21.

PMID:
22187200
5.

Noninvasive assessment of coronary vasodilation using cardiovascular magnetic resonance in patients at high risk for coronary artery disease.

Nguyen PK, Meyer C, Engvall J, Yang P, McConnell MV.

J Cardiovasc Magn Reson. 2008 May 30;10:28. doi: 10.1186/1532-429X-10-28.

6.

Noninvasive assessment of coronary vasodilation using magnetic resonance angiography.

Terashima M, Meyer CH, Keeffe BG, Putz EJ, de la Pena-Almaguer E, Yang PC, Hu BS, Nishimura DG, McConnell MV.

J Am Coll Cardiol. 2005 Jan 4;45(1):104-10.

7.

Impaired coronary vasodilation by magnetic resonance angiography is associated with advanced coronary artery calcification.

Terashima M, Nguyen PK, Rubin GD, Iribarren C, Courtney BK, Go AS, Fortmann SP, McConnell MV.

JACC Cardiovasc Imaging. 2008 Mar;1(2):167-73. doi: 10.1016/j.jcmg.2007.12.001.

8.

Coronary and systemic hemodynamic effects of the putative nitric oxide donor, FK 409, in comparison with nitroglycerin in conscious and anesthetized dogs.

Drieu la Rochelle C, Lainée P, Grosset A, O'Connor SE.

J Cardiovasc Pharmacol. 1995 Oct;26(4):555-63.

PMID:
8569215
9.

Metabolic coronary-flow regulation and exogenous nitric oxide in human coronary artery disease: assessment by intravenous administration of nitroglycerin.

Kal JE, Van Wezel HB, Porsius M, Vergroesen I, Spaan JA.

J Cardiovasc Pharmacol. 2000 Jan;35(1):7-15.

PMID:
10630728
10.

Appropriate timing of nitroglycerin prior to intravascular ultrasound.

Ahmed B, Martinez JD, Schevchuck A, Ahmed S, Schrader R, Peralta MA, Sheldon MW, Ricciardi MJ.

J Invasive Cardiol. 2012 Sep;24(9):422-6.

11.

Association between brachial-ankle pulse wave velocity and endothelium-dependent and -independent coronary vasomotor function.

Yoshino T, Nakae I, Matsumoto T, Mitsunami K, Horie M.

Clin Exp Pharmacol Physiol. 2011 Jan;38(1):34-41. doi: 10.1111/j.1440-1681.2010.05455.x.

PMID:
21039754
12.

Influence of applying nitroglycerin in whole-heart free-breathing 3D coronary MR angiography.

Jin H, Zeng MS, Ge MY, Ma JY, Chen CZ, Shen JZ, Li RC.

AJR Am J Roentgenol. 2010 Apr;194(4):927-32. doi: 10.2214/AJR.09.3330.

PMID:
20308493
14.

Nitroglycerin-induced coronary vasodilation is not enhanced in patients with impaired endothelium-dependent dilation.

Anderson TJ, Meredith IT, Charbonneau F, Yeung AC, Dyce M, Selwyn AP, Ganz P.

J Am Coll Cardiol. 1996 Sep;28(3):580-4.

15.

Vascular smooth muscle responsiveness to nitric oxide is reduced in healthy adults with increased adiposity.

Christou DD, Pierce GL, Walker AE, Hwang MH, Yoo JK, Luttrell M, Meade TH, English M, Seals DR.

Am J Physiol Heart Circ Physiol. 2012 Sep 15;303(6):H743-50. doi: 10.1152/ajpheart.00394.2012. Epub 2012 Jul 20.

16.

N-acetylcysteine improves coronary and peripheral vascular function.

Andrews NP, Prasad A, Quyyumi AA.

J Am Coll Cardiol. 2001 Jan;37(1):117-23.

17.

Nitrate-induced coronary vasodilation by stress-magnetic resonance imaging: a novel noninvasive test of coronary vasomotion.

Pepe A, Lombardi M, Takacs I, Positano V, Panzarella G, Picano E.

J Magn Reson Imaging. 2004 Sep;20(3):390-4.

PMID:
15332245
18.

Adrenomedullin causes coronary vasodilation in humans: effects of inhibition of nitric oxide synthesis.

Ueda K, Teragawa H, Kimura M, Matsuda K, Higashi Y, Yamagata T, Oshima T, Yoshizumi M, Chayama K.

J Cardiovasc Pharmacol. 2005 Oct;46(4):534-9.

PMID:
16160609
19.

Influence of captopril on nitroglycerin-mediated vasodilation and development of nitrate tolerance in arterial and venous circulation.

Pizzulli L, Hagendorff A, Zirbes M, Fehske W, Ewig S, Jung W, Lüderitz B.

Am Heart J. 1996 Feb;131(2):342-9.

PMID:
8579031
20.

Nitroglycerin-induced coronary vasodilation in cardiac transplant recipients. Evaluation with in vivo intracoronary ultrasound.

Pinto FJ, St Goar FG, Fischell TA, Stadius ML, Valantine HA, Alderman EL, Popp RL.

Circulation. 1992 Jan;85(1):69-77.

PMID:
1728486

Supplemental Content

Support Center